You're viewing 1 of thousands of M&A events in our database
Members track acquisition patterns and get alerts on companies likely to buy or sell. Access deal terms, multiples, and strategic rationale.
Acquiring Company
Versiti
Acquired Company
Quantigen
Description
Versiti, a national leader in blood health innovation, today announced the acquisition of Quantigen, a specialty lab based in Fishers, Indiana. Further expanding Versiti's clinical trial expertise and service offering, Quantigen provides a range of services supporting preclinical and clinical research as well as clinical diagnostics. The Quantigen team specializes in assay development, biomarker validation, and diagnostic regulatory filings for a wide range of methods and disease states. The Quantigen team is particularly proud of ongoing partnerships with NGOs to adapt existing diagnostic technologies for use in lower- and middle-income countries to address significant unmet diagnostic and health needs in these communities.